🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#EYEG +60% Eyegate Pharmaceuticals Inc - after the company received FDA approval to initiate its photorefractive keratectomy pivotal study.

#HTBX +26% Heat Biologics Inc - after the company announced interim Phase 2 lung cancer data showing that its HS-110 demonstrated clinical activity in tumor patients.

#CY +26% Cypress Semiconductor Corporation- confirmed it has agreed to be acquired by Infineon Technologies AG #IFNNY
for $23.85 per share in cash, translating to an enterprise value of 9 billion euros, or $10.05 billion.

#GNCA +25% Genocea Biosciences, Inc. - after the company presented results from its ongoing Phase 1/2a trial for GEN-009, the company's lead neoantigen vaccine candidate, at ASCO 2019.

#MDGS +15% Medigus Ltd. - after the company signed a $3 million agreement with Golden Grand for the licensing and sale of goods for Medigus Ultrasonic Surgical Endostapler system in greater China.

#EE +14% El Paso Electric Company - after the company agreed to be acquired by the Infrastructure Investments Fund for $68.25 per share in cash.

#NNVC +13% NanoViricides Inc - after the company received 'favorable' comments from the FDA regarding its pre-IND application for its lead drug candidate.

#VICL +10% Vical Incorporated - after the company announced an all-stock merger agreement with Brickell Biotech.

#WLL +10% Whiting Petroleum Corporation

#NKTR +9% Nektar Therapeutics - after presenting biomarker and clinical data from PIVOT-02 Phase 2 study of bempegaldesleukin with nivolumab at the ASCO Annual Meeting.

#MAXR +9% Maxar Technologies Inc. - after winning $95 million of US Government contracts.

#CANF +9% Can-Fite BioPharma Ltd. -after the company presented data from its recently completed Phase II trial in patients with hepatocellular cancer at the American Society of Clinical Oncology (ASCO).

#CLDX +7% Celldex Therapeutics, Inc. - after presenting results from the CDX-3379 clinical program at the 2019 American Society of Clinical Oncology Annual Meeting in Chicago.

#LK +6% Luckin Coffee Inc.- after gaining 8% on Friday.

#HMI +6% Huami Corporation- after reporting a first-quarter earnings beat.

#OTLK +5% Outlook Therapeutics, Inc. - after signing a manufacturing supply agreement with FUJIFILM Diosynth Biotechnologies as a part of commercialization strategy for ONS-5010.

#BC +5% Brunswick Corporation

#GBT +4% Global Blood Therapeutics, Inc.

#TEVA +3% Teva Pharmaceutical Industries Ltd - Oppenheimer upgraded Teva Pharmaceutical from Perform to Outperform and announced a $12 price target.

ВНИЗ

#FTD -84% FTD Companies Inc -after the company filed voluntary Chapter 11 petitions to facilitate the completion of strategic initiatives. The company will also be delisted from the Nasdaq.

#CNC -8% Centene Corporation-after Reuters reported that Humana has confirmed it will not make a proposal to combine with Centene.

#BLIN -5% Bridgeline Digital, Inc. -after declining 16% on Friday.

#BIG -5% Big Lots, Inc. - Bank of America downgraded Big Lots from Buy to Underperform.

#CBS -5% CBS Corporation

#INFN -4% Infinera Corporation -JP Morgan downgraded Infinera from Neutral to Underweight.

#USNA -4% USANA Health Sciences, Inc.

#AMPH -4% Amphastar Pharmaceuticals, Inc.

#DB -3% Deutsche Bank

#GOOGL -3% Alphabet Inc.- after the Justice Department announced an antitrust investigation into Google.

⚡️🇺🇸#CNC #отчетности #сша
Centene Q4 19 Earnings:
- Revenue: $18.9B (exp $18.43B)
- Adj EPS: $0.73 (exp $0.73)

⚡️🇺🇸#CNC #отчетности #сша
Centene Q1 20 Earnings:
- Revenue: $26.0B (exp $24.31B)
- Adj EPS: $0.86 (exp $1.01)
- Revenue Guidance Increased

⚡️🇺🇸#отчетности #сша

#MMM 3M Q2 Non-GAAP
-EPS of $1.78 misses by $0.01; GAAP EPS of $2.22 beats by $0.41.
-Revenue of $7.18B (-12.1% Y/Y) misses by $110M.
-Organic growth of -13.1% missing consensus of -10.4%.

#SITC SITE Centers Q2
-FFO of $0.21 beats by $0.02.
-Revenue of $98.26M (-13.4% Y/Y) misses by $0.39M.

#AMAL Amalgamated Bank Q2 Non-GAAP
-EPS of $0.34 beats by $0.09; GAAP EPS of $0.33 beats by $0.09.
-Revenue of $53.11M (+10.2% Y/Y) beats by $2.9M.

#TRU TransUnion Q2 Non-GAAP
-EPS of $0.66 beats by $0.17; GAAP EPS of $0.36 beats by $0.11.
-Revenue of $634M (-4.2% Y/Y) beats by $47.68M.

#OTIS Otis Worldwide Q2 Non-GAAP
-EPS of $0.56 beats by $0.12; GAAP EPS of $0.52 beats by $0.14.
-Revenue of $3.03B (-9.6% Y/Y) beats by $110M.
-Adj operating margin of 15.1% improves by 30bps Y/Y.

#AWI Armstrong World Q2 Non-GAAP
-EPS of $0.75 misses by $0.16; GAAP EPS of $1.03 beats by $0.12.
-Revenue of $203.2M (-25.3% Y/Y) misses by $17.85M.

#MDC M.D.C. Holdings Q2 GAAP
-EPS of $1.31 beats by $0.48.
-Revenue of $886.76M (+21.0% Y/Y) beats by $80.02M.

#PII Polaris Q2 Non-GAAP
-EPS of $1.30 beats by $0.65; GAAP EPS of -$3.82 misses by $4.42.
-Revenue of $1.51B (-15.2% Y/Y) beats by $140M.
-Adj gross margin of 23% vs. consensus of 21.8%.

#CNC Centene Q2 Non-GAAP
-EPS of $2.40 misses by $0.03; GAAP EPS of $2.05 beats by $0.08.
-Revenue of $27.72B (+51.0% Y/Y) beats by $240M.
-Health benefits ratio of 82.1% vs. consensus of 82.3%.

#HUN Huntsman Q2 Non-GAAP
-EPS of -$0.14 beats by $0.04; GAAP EPS of -$0.28 misses by $0.14.
-Revenue of $1.25B (-29.8% Y/Y) beats by $120M.
-Adjusted EBITDA of $54M, compared to consensus of $38.1M.
-Free cash flow from continuing operations of $30M.

#PRLB Proto Labs Q2 Non-GAAP
-EPS of $0.59 beats by $0.23; GAAP EPS of $0.47 beats by $0.22.
-Revenue of $106.58M (-8.0% Y/Y) beats by $6.12M.

#ST Sensata Technologies Q2 Non-GAAP
-EPS of $0.18 beats by $0.02; GAAP EPS of -$0.27 misses by $0.18.
-Revenue of $576.51M (-34.8% Y/Y) in-line.

⚡️🇺🇸#CNC #отчетность
Centene Q320 Earnings:
-Revenue: $29.1B (est: $28.25B)
-Adj EPS: $1.26 (est: $0.96)
-Sees FY Rev: $109.8B To $111.4B (prev: $109B To $111.4B)
-Sees FY Adj EPS: $4.90 To $5.06 (prev: $4.76 To $4.96)